Ruijian Capital Management

Ruijian Capital Management (瑞健资本) is a leading Chinese healthcare-focused investment firm headquartered in Shanghai. Established in 2015, it serves as the management company for the Shanghai Health Care Industry Equity Investment Fund, which was co-founded by Shanghai Pharmaceuticals (SPH) and Ruili Investment. The firm specializes in strategic investments across the life sciences ecosystem, including biotechnology, innovative pharmaceuticals, high-end medical devices, and digital health services. By leveraging the industrial background and resources of its key backer, Shanghai Pharmaceuticals, Ruijian Capital provides both financial support and operational expertise to early-to-growth stage companies. Its portfolio includes notable investments in areas such as ophthalmology, oncology, and medical informatics.